Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Heart Failure POC and LOC Devices Companies

ID: MRFR/HC/9169-HCR
120 Pages
Vikita Thakur
Last Updated: February 16, 2025
Dedicated to cardiovascular health, Heart Failure POC & LOC Devices companies focus on developing Point-of-Care (POC) and Lab-on-Chip (LOC) devices. Their innovative solutions enable rapid and accurate diagnostics for heart failure, supporting timely interventions and improving patient outcomes in cardiovascular care.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Heart Failure POC and LOC Devices Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)16.5%
2024 Market Size$ 67.8 Million
2025 Market Size$ 78.99 Million
2035 Market Size$ 363.85 Million
Key Players
Abbott
Medtronic
Boston Scientific
Philips
Bayer
Roche
Trends
  • Technological Advancements
  • Shift Towards Telehealth
  • Focus on Patient-Centric Solutions
Opportunities
  • Market Growth Projections
  • Rising Prevalence of Heart Failure
  • Increased Focus on Preventive Healthcare
Summary Table of Contents Segmentation Methodology Download PDF

Top Industry Leaders in the Heart Failure POC and LOC Devices Market

Heart Failure POC & LOC Devices Key Companies
 
Latest Heart Failure POC & LOC Devices Companies Update:

Abbott Laboratories Launched the i-STAT BNP Test in December 2023, offering a rapid and portable POC test for B-type natriuretic peptide (BNP), a key marker for heart failure.

Roche Diagnostics Introduced the Elecsys® proBNP 2nd Generation assay in July 2023, providing increased sensitivity and specificity for BNP testing on their laboratory analyzers.

Lumio Diagnostics Received FDA clearance for their LUMIO™ Platform in October 2023, which includes a portable system for rapid, multi-analyte testing, including biomarkers for heart failure.

Singal™ Biometrics Developing a LOC device capable of simultaneously measuring multiple heart failure biomarkers on a single chip, offering rapid and comprehensive diagnosis.

Cardiome Dx Collaborating with other companies to develop and integrate AI-powered algorithms into their heart failure POC devices, enhancing diagnostic accuracy and providing real time insights.

List of Heart Failure POC & LOC Devices Key companies in the market

  • Abbott (US)

  • F. Hoffmann-La Roche Ltd. (Switzerland)

  • Danaher (US)

  • Abaxis, Inc. (US)

  • Quidel Corporation (US)

  • Siemens Healthineers (Germany)

  • JantPharmacal Corporation (US)

  • Trinity Biotech (Ireland)

  • bioMérieux S.A (France)

  • Instrumentation Laboratory Company (US)

Related Reports

No regional reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035